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A B S T R A C T
Introduction: This study examined associations of health-related quality of life (HRQOL), anxiety, and
depression with medical and psychosocial variables. Participants were young adults with epilepsy and
additional mild cognitive impairments in short-term residential care of the Bethel Institute, Germany.
Methods: Thirty-six individuals were interviewed using the Quality of Life in Epilepsy Inventory 31
(QOLIE-31), the Hospital Anxiety and Depression Scale (HADS) and the neuroticism scale of the Neo-Five-
Factor Inventory (NEO-FFI). Medical as well as socio-demographic data were assembled from client ﬁles.
Results: Regression analyses revealed neuroticism as the strongest predictor of HRQOL, anxiety and
depression. The only variables that additionally explained a substantial proportion of variance counting
for 6–10% in the three criteria were age at epilepsy onset and sex: epilepsy onset after the age of 10 years
was associated with lower HRQOL and higher anxiety, men suffered from more depression than women.
Discussion: Neuroticism as a personality disposition seems to be most inﬂuential on HRQOL and anxiety
in people with epilepsy and mild cognitive impairment. The impact of sex and age at epilepsy onset on
HRQOL, anxiety and depression of this epilepsy subpopulation should be further clariﬁed.
 2008 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Health-related quality of life (HRQOL) and affective disorders of
patients with epilepsy are the subject of scientiﬁc discussions for a
long period of time. A relationship between epilepsy and affective
disorders is well-known and depression and anxiety were shown
to be the most frequent psychological disorders in epilepsy.1–5 In
the last decade HRQOL has been established as a new outcome
measure in addition to seizure control in treatment studies.6–8
The question of identifying determinants of affective disorders
and HRQOL is of particular interest. Hermann and Whitman
hypothesized three groups of variables that contribute to under-
standing psychological problems of people with epilepsy: neuro-
epilepsy variables such as seizure frequency, seizure type, age
at onset or duration of epilepsy; medication variables such as
medication type and number; psychosocial variables such as
adjustment to the epilepsy or perceived stigma.9 Unfortunately* Corresponding author. Tel.: +49 521 144 2802; fax: +49 521 144 6274.
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doi:10.1016/j.seizure.2008.08.013only few conclusions can be drawn based on empirical data:
regarding epilepsy parameters, many studies showed a substantial
impact of seizure control on HRQOL, especially when groups
without seizure control were compared with groups with seizure
control.10–15 An impact of seizure control on affective disorders
was demonstrated less consistently.16 As regards medication
factors, effects of some antiepileptic drugs (AEDs) on HRQOL and
affective disorders were documented.11,17–20 In comparison to
disease or iatrogenic parameters, psychosocial variables were
usually found to be even stronger related to HRQOL21–24 and to
affective disorders.3 But their signiﬁcance remains doubtful: for
example, HRQOL, depression and anxiety correlate with each
other. Today, associations between HRQOL and depression are
mostly regarded as inﬂuences of depression on HRQOL.22,23 In the
past, parameters of psychosocial adaptation to epilepsy weremore
often discussed as risk factors for psychiatric disorders such as
depression.9Many of these parameters are nowadays incorporated
in the HRQOL construct. Altogether, the role of psychosocial
factors on adjustment and treatment outcome in epilepsy is still far
from clear. Among the psychological variables the potential of
personality traits to determine psychopathology of patients with
epilepsy or patients with psychogenic non-epileptic seizures has
only recently gained attention: the role of neuroticism, one of thevier Ltd. All rights reserved.
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in some studies and an inﬂuence of neuroticism on general well-
being in patients with epilepsy was documented.21,25–29 In
contrast to relatively little research in epilepsy, studies from the
general population or from psychiatric patients indicate that
neuroticism is a strong risk factor for manifest psychiatric
disorders30 and a potential general underlying vulnerability factor
for psychopathology.31 It was shown that high neuroticism scores
predict poor outcome in depression32,33 and are also associated
with lower quality of life.34
The aim of this cross-sectional study was to analyze the
relationships of HRQOL, depression and anxiety with psycho-
social and medical variables in a very special ‘‘epilepsy plus’’
group of the Bethel Institute, Germany. We assumed HRQOL,
depression and anxiety to be changeable over time and there-
fore examined them as dependent target variables. Based on
theory, we chose neuroticism as a more time-stable persona-
lity trait and possibly determining independent psychological
variable for the three criteria. We were interested to ﬁnd out
the relative impact of neuroticism on HRQOL, anxiety and
depression in comparison with disease and socio-demographic
variables.
Studies on factors associated with HRQOL and psychological
symptoms regularly concentrate on groups of people with epilepsy
that are essentially deﬁned bymedical parameters: categoriesmay
be epileptic syndromes such as temporal lobe epilepsy or juvenile
myoclonic epilepsy, treatments such as epilepsy surgery or
‘‘epilepsy only’’ groups without co-morbidity. In contrast, we
were interested in detecting possible associations in clients of the
‘‘Wohnheimverbund fu¨r junge Erwachsene mit Epilepsie’’ (WJE),
which is a short-term residential unit for young adults with
epilepsy and additional disabilities from all over Germany. The
WJE provides training over approximately 3 years in order to
achieve a more autonomous life. WJE clients are – besides the
diagnosis of difﬁcult-to-treat-epilepsy – selected with respect to
psychosocial indicators.35
Criteria for admission to this ‘‘epilepsy plus’’ group in Bethel are
the following:(a) Age: Clients are generally 18–35 years old.
(b) Epilepsy: All of the clients have a diagnosis of difﬁcult-to-treat-
epilepsy but vary considerablywith respect to syndromes, drug
treatment and anamnestic features.(c) Cognitive impairment: In addition to epilepsy all of the clients
have a diagnosis of more general or more speciﬁc cognitive
limitations due either to the epilepsy or underlying brain
dysfunction itself, to the complications of epilepsy or to
antiepileptic drugs. Nevertheless, they are able to commu-
nicate verbally and are not severely mentally retarded.(d) Psychosocial functioning: Chronic epilepsy and/or cognitive
limitations have resulted in signiﬁcant problems of psychoso-
cial functioning. Clients had difﬁculties at school or job training
and were unable to ﬁnd a job on the general job market. Many
had also experienced problems in the family home such as
overprotection or felt socially isolated.
Clients or their relatives regularly ask for admission to theWJE.
Very often their neurologists or other institutions of social or
medical rehabilitation arrange the ﬁrst contact. The epilepsy
clinic Mara I of the Bethel Institute plays a special role with a
substantial proportion of inquiries for admission. An executive
committee of the WJE decides about admission according to
the above-mentioned criteria based on available school records,
medical ﬁles and further biographical material. Members of the
committee are the administrative head of the WJE, staff members,and three responsible experts: a medical specialist in neurology
and psychiatry, a clinical psychologist and a social worker. The
WJE is funded by the German social welfare system.
2. Materials and methods
2.1. Characteristics of the sample
Thirty-six of 40WJE clients, i.e. 90% of the population, took part
in the study. The sample consisted of 14 female (38.9%) and 22
male (61.1%) clients. None of them were married. Their mean age
was 25.6 years (S.D. = 6.0;median = 24.0; range = 18–40). All of the
following data on (1) epilepsy and treatment, (2) psychiatric co-
morbidity and (3) education, cognitive functioning and work were
drawn solely from client ﬁles.1. The mean number of different seizure types was 3.0 (S.D. = 1.1;
median = 3.0; range = 1–5) and the most frequent seizure types
were primarily or secondary generalized tonic–clonic seizures,
complex partial and simple partial seizures. During the 6months
prior to data collection, 28 clients (77.8%) had seizures; the
remainder were seizure-free. This relatively high percentage of
seizure-free clients may be surprising considering a sample with
difﬁcult-to-treat-epilepsy. As data were not gained at admission
to the WJE, they eventually indicate successful medical inter-
ventions during the time already spent in the rehabilitation unit.
An idiopathic generalized epilepsy was diagnosed in only four
clients (11.1%),whereas 32 (88.9%) suffered fromsymptomatic or
cryptogenic partial epilepsy. Among thesewere12personswith a
deﬁnite temporal lobe origin (TLE).Mean age at onset of epileptic
seizures was 7.6 years (S.D. = 7.2; median = 5.0; range = 0–23).
Twenty-four clients had their ﬁrst epileptic seizure before the age
of 11 years, 12 clients had an epilepsy onset in adolescence.Mean
duration of epilepsy was 18.0 years (S.D. = 9.2; median = 17.0;
range = 2–39). Clients were treated with 2.2 AEDs on average
(S.D. = 1.0;median = 2.0; range = 1–5). Lamotrigineandvalproate
were most frequently prescribed, followed by oxcarbazepine.
Eight patients (22.2%) had been treated surgically prior to
residential care without reaching complete seizure control.
Two patients (5.6%) were treated with vagus nerve stimulation
in addition to AEDs and three (8.3%) had a ventricle drainage
(shunt).2. Psychiatric diagnoses based on ICD-10 or DSM-IV were not
available. Nevertheless, the following data indicate current
psychiatric symptomatology: seven clients (19.4%) were treated
with psychotropic medication in addition to AEDs and nine
clients (25.0%) had psychogenic non-epileptic seizures in
addition to epileptic seizures.3. Eighteen persons (50%) had attended special education schools
for people with learning or physical disabilities. As it is possible
to achieve a basic education equivalent in special education
schools in Germany, altogether 28 persons (77.8%) achieved
mainstream basic education certiﬁcation. Previous IQ reports
were available for only 12 persons (IQ range = 71–108):
according to them seven clients scored between 70 and 80,
three between 81 and 100 and two had IQ scores >100. At the
time of data collection, two clients did not work, the other 34
worked in sheltered workshops of the Bethel Institute. While no
client was classiﬁed as mentally retarded (IQ < 70), the school
type attended as well as the comparatively smaller portion of
people having completed basic education clearly indicates an
altogether sub average IQ sample proﬁle. Mild cognitive
impairments were also indicated by staff-observations: 14
persons (38.9%) had been rated with more severe memory
deﬁcits in everyday situations.
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HRQOL and personality dimensions such as neuroticism are
usually measured by self-rating scales. Self-rating scales are also
often used as indicators of psychiatric disorders. With regard to
clients of the WJE we were interested in choosing questionnaires
easily to understand and commonly used in medical and
psychological research. We decided to administer the question-
naires in face-to-face interviews in order to motivate individuals
with a limited attention span, little reading experience or reading
difﬁculties. Additionally, it sought to guarantee participation with
a minimum of missing values. The application of self-rating
scales in face-to-face interviews seemed suitable as there are no
indications of a general relationship between the presentation of
questionnaires (e.g. face-to-face interview vs. postal inquiry) and
response tendencies.36 Moreover, studies of people with mild
intellectual disabilities have demonstrated the utility of self-rating
scales to measure quality of life37 and psychiatric symptoms38,39
when administered in face-to-face interviews. Promising results
with regard to reliability and validity have also been gained with
other epilepsy patients of the Bethel Institute.40–42
2.2.1. Health-related quality of life: QOLIE-31
The Quality of Life in Epilepsy-31 Inventory (QOLIE-31) by
Cramer et al.43 was chosen to measure epilepsy-speciﬁc HRQOL.
We used a German version previously tested psychometrically.44
The QOLIE-31 has been shown to be a valid and reliable
questionnaire and is internationally recognized as one of the best
studied instruments to measure HRQOL in epilepsy.45 The
questionnaire consists of 30 items that are subsumed to seven
subscales with two to six items in each case. An additional item
covers the general health status. Raw scores are transformed to a
0–100 scale. Higher scores indicate better HRQOL. This study
exclusively refers to the total score which is the result of subscale
means under consideration of regression analytic subscale
weightings. The total score also ranges between 0 and 100.
The Portuguese/Brazilian version of the QOLIE-31 inventory
had already shown good reliability and validitywhen administered
in face-to-face interviews.46 Interviews were conducted as there
was concern over the low educational and socioeconomic level of
the respondents. Besides, interviews are a common method of
questionnaire studies in Brazil.
2.2.2. Anxiety and depression: HADS
TheGermanversionof theHospital AnxietyandDepressionScale
(HADS) was used to screen for anxiety and depression.47 It is a brief
and internationally used self-rating scale with 14 items,48 which
seeks to identify anxiety and depression as the most common
secondary psychiatric disturbances in persons with primarily
somatic complaints. All items are to be answered on four-point
scalesbetween0and3. Twosubscale scores are computedbysimply
adding the raw scores of each scale (range = 0–21). Our patients
were requested to answer all items according to their experience
during the past week. The HADS had also previously been used in
face-to-face interviews: according to expectations, Nigerians with
epilepsy scored higher on anxiety and depression.49 An interviewer
read the questions for illiterate subjects.
2.2.3. Neuroticism: NEO-FFI
The Neo-Five-Factor Inventory (NEO-FFI) by Costa and
McCrae50 is a screening instrument to gain data on the ﬁve
personality dimensions neuroticism, extraversion, agreeableness,
conscientiousness and openness to experience. Each dimension is
represented by 12 items that have to be answered on ﬁve-point
scales between 0 and 4. Means are computed for subscales so thattheir maximum score is 4 as well. Only the subscale neuroticism
from the German NEO-FFI version51 was used.
2.3. Data collection
In 2005 the three questionnaires were read aloud to each client
by one of the authors (F.Z.) who worked at that time for the
Psychological Service of the Bethel Institute. The interviewee did
not know the clients before the time of the interviews and was not
involved in any further professional assistance for them. Clients
were volunteers. The interviewee found no evidence for clients
being unable to understand the questions or the measurement
with multi-point scales. Therefore data analyses included all WJE
clients who had been willing to participate in the study. Never-
theless, the time of the interviews varied considerably (mean
time = about 1 h; range = 0.5–2.5 h). Some clients reacted slowly
on the questionnaires, some easily paid attention to special aspects
brought up by single items and then carefully had to be led back to
the remaining questions. Altogether, time-consuming interviews
were attributable to motivational problems of some clients or to
problems with alertness. A standardised rephrasing of items was
neither planned nor necessary.
2.4. Data analysis
SPSS for windows, Version 12.0, was used for data analysis. At
ﬁrst the assumption of rating scales’ normal distribution was
checked. Kolmogorov–Smirnov tests failed to ﬁnd signiﬁcant
deviations (rejection at p < .20) so that further analyses were
performed using parametric two-tailed statistics. Cronbach’s a
was regularly calculated as a measure of internal consistency. For
the weighted QOLIE-31 total score reliability was estimated
according to Mosier.52 Pearson correlation coefﬁcients or point-
biserial correlation coefﬁcients were performed to look for the
relation between variables and t-tests to look for group differences.
Fisher’s exact tests were computed to detect possible differences
between binary variables. As the sample size was small and the
data analysis was heuristic in nature, no a error correction was
conducted despite of some variables incorporated in multiple
comparisons. In addition to bivariate analyses, three stepwise
regression analyses were performed in order to predict the QOLIE-
31 total score and the HADS-scores anxiety and depression.
3. Results
3.1. QOLIE-31, HADS and NEO-FFI: distribution of scores, internal
consistency, comparisons with reference samples
The internal consistencies of the self-rating scales always
exceededCronbacha scores of .70 in theWJE sample. In comparison
to the larger US-American epilepsy sample by Cramer et al.43 the
WJE clients scored signiﬁcantly higher on the QOLIE-31 total
score, i.e. they reportedabetterHRQOLonaverage. Furthermore, the
range of the QOLIE total score was smaller. NEO-FFI-neuroticism
scores did not differ between the WJE clients with epilepsy and
a German reference group.51 Finally, in comparison to a sample
of the German general population47 HADS-anxiety scores were
signiﬁcantly elevated (see Table 1).
3.2. Relations between scores of self-rating scales and socio-
demographic as well as disease variables
Table 2 demonstrates the relation of socio-demographic
variables, disease and medical treatment variables with ques-
tionnaire scores on HRQOL, anxiety, depression and neuroticism.
Table 1
QOLIE-31, NEO-FFI-neuroticism and HADS: comparison of WJE scores with larger reference samples
Number of items M S.D. Range Internal
consistency
M S.D. Range Internal consistency p (t-test)
WJE clients of this study (N = 36)
QOLIE-31 Cramer et al. [43] (N = 298–304)a
Total score 30 69.32 12.52 48–96 .84b 63.00 16.00 15–97 .93b *
NEO-FFI Borkenau and Ostendorf [51]
(N = 2112)c
Neuroticism 12 1.74 0.83 0.33–3.33 .85d 1.84 0.70 .85d ns
HADS Hermann et al. [47] (N = 152)e
Anxiety 7 6.89 3.60 0–13 .74d 5.80 3.20 .80d *
Depression 7 3.94 3.68 0–16 .85d 3.40 2.60 .81d ns
M: mean, S.D.: standard deviation; ns: non signiﬁcant, *p  .05 (two-tailed).
a US-American patients with epilepsy.
b Reliability estimation according to Mosier.
c German sample with overrepresentation of university students.
d Internal consistency according to Cronbach’s a.
e German general population, but Cronbach’s a according to German cardiac patients (N = 5338).
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psychological variables neuroticism, anxiety, depression and
HRQOL. Neuroticism, anxiety and depression were positively
correlated with each other and were negatively correlated with
HRQOL.
Among variables on disease and medical treatment, only age at
epilepsy onset was associated with two questionnaire scores:
clients with epilepsy onset after the age of 10 scored lower on the
QOLIE total score and higher on the HADS anxiety score. We
distinguished two categories instead of analyzing age at onset as a
continuous variable. The age of 11 years was chosen as the cutoff
point according to developmental psychology that describes
adolescence as the life span between the age of 11 and 21 years.53
No signiﬁcant relation could be detected between scores on
HRQOL, anxiety, depression and disease parameters such as
seizure control, number of AEDs or memory impairments.
Two socio-demographic parameters were associated with
HADS scores: a moderate positive correlation coefﬁcient was
detected between anxiety and age. Furthermore, men had signi-
ﬁcantly higher depression scores than women.
3.3. Prediction of the QOLIE-31 total score and HADS scores
We computed three stepwise regression analyses to identify
predictors for the QOLIE-31 total score and the HADS scores
anxiety and depression. Due to the assumptions mentioned above
and due to the high inter-correlations of the rating scales, we chose
neuroticism as a possible psychological predictor for the three
criteria HRQOL, anxiety and depression. In addition to neuroticism
those socio-demographic and disease parameters were included as
independent variables that had also demonstrated a substantial
relationship (p < .05) with the QOLIE-31 total score and the HADS
scores in bivariate analyses as shown in Table 2.
Table 3 demonstrates that neuroticism remained as indepen-
dent predictor throughout all analyses. Neuroticism alone
explained 46–54% of the variance of anxiety, depression and
HRQOL. The incorporation of age at epilepsy onset in addition to
neuroticism improved variance explanation for 7% in HRQOL and
for 6% in anxiety. The incorporation of sex improved variance
explanation for additional 10% in depression with men being at
special risk.
No signiﬁcant correlations were found between those variables
that were entered as independent predictors for HRQOL, anxiety or
depression, neither between neuroticism, age and age at epilepsy
onset nor between neuroticism and sex.3.4. Relationship between age at disability onset and socio-
demographic as well as disease variables
Bearing the fact that the inﬂuence of age at epilepsy onset on
HRQOL and anxiety could have been amere artefact based on other
smaller effects of disease parameters, we looked for possible
differences between the groups with early and later epilepsy onset
concerning all socio-demographic, disease and treatment variables
outlined in Table 2. We only found two differences: signiﬁcantly
more young men were among those with later epilepsy onset.
Additionally, the duration of epilepsywas shorter in the groupwith
later onset (see Table 4).
4. Discussion
Summarizing our main ﬁndings: psychological variables
such as neuroticism, anxiety, depression and HRQOL highly
correlated with one another. Thus, it was not surprising that
regression analyses revealed neuroticism to be the strongest
predictor of HRQOL, anxiety and depression. Among the disease-
related variables, only age at epilepsy onset had a substantial
inﬂuence on two criteria which adds independently to neuroti-
cism: epilepsy onset in adolescence was associated with reduced
HRQOL and with anxiety. In addition to neuroticism, sex had an
inﬂuence on depression: men were at greater risk. Other disease
or treatment variables such as seizure control or number of AEDs
showed no striking effects on HRQOL, anxiety and depression in
this study.
With respect to methodological aspects: the observations
during the interviews did not argue against the application of the
scales. We regard the expected correlations between the
questionnaires and their internal consistencies as indicators for
the reliability and validity of the self-rating scales in our sample
of people with epilepsy and additional mild cognitive impair-
ments. Furthermore, we have already compared the QOLIE-31
interview data of our clients with QOLIE-31 ratings of their carers
and found that their caregivers systematically underrated our
clients’ HRQOL.54 These results are in line with most data on
relations between self-reported HRQOL and proxy reports. Thus
they do not point to a special response tendency in our sample
due to the presentation of the scales. Nevertheless, such ﬁndings
cannot ﬁnally clarify if and in how far responses of theWJE clients
to the questionnaires were inﬂuenced or distorted by face-to-face
interviews.
Table 2
Relations between QOLIE-31 total score, neuroticism, anxiety, depression and socio-demographic as well as disease and treatment variables (N = 36)
I. t-tests for independent samples QOLIE-31: total score HADS: anxiety HADS: depression NEO-FFI: neuroticism
M (S.D.) p M (S.D.) p M (S.D.) p M (S.D.) p
Sex
Female (n = 14) 72.88 (13.17) ns 6.71 (3.60) ns 2.64 (1.95) * 1.77 (0.77) ns
Male (n = 22) 67.05 (11.83) 7.00 (3.68) 4.77 (4.29) 1.72 (0.88)
Basic education certiﬁcation
No (n = 8) 67.85 (11.86) ns 6.75 (3.62) ns 6.00 (3.86) ns 2.02 (0.84) ns
Yes (n = 28) 69.74 (12.88) 6.93 (3.66) 3.36 (3.48) 1.66 (0.82)
Seizure controla
No seizures (n = 8) 74.38 (13.75) ns 6.38 (3.34) ns 3.13 (3.27) ns 1.53 (0.87) ns
Seizures (n = 28) 67.87 (12.01) 7.04 (3.72) 4.18 (3.81) 1.80 (0.82)
Psychogenic non-epileptic seizures
No (n = 27) 70.51 (13.10) ns 6.41 (3.81) ns 3.45 (2.98) ns 1.64 (0.77) ns
Yes (n = 9) 65.74 (10.42) 8.33 (2.55) 5.33 (5.24) 2.03 (0.96)
Epilepsy onset
11 years (n = 12) 63.60 (9.21) * 8.42 (2.19) * 5.17 (4.45) ns 1.83 (0.96) ns
<11 years (n = 24) 72.18 (13.13) 6.13 (3.95) 3.33 (3.16) 1.69 (0.77)
Epilepsy syndrome
Partial (n = 32) 69.46 (12.70) ns 6.88 (3.60) ns 3.69 (3.20) ns 1.70 (0.82) ns
Generalized (n = 4) 68.24 (12.67) 7.00 (4.08) 6.00 (6.78) 2.06 (0.92)
TLE
No (n = 24) 69.49 (12.87) ns 7.21 (3.88) ns 3.71 (3.86) ns 1.78 (0.94) ns
Yes (n = 12) 68.98 (12.32) 6.25 (3.02) 4.42 (3.40) 1.65 (0.55)
Memory impairments
No (n = 22) 71.48 (13.95) ns 6.73 (4.06) ns 4.09 (4.25) ns 1.73 (0.90) ns
Severe (n = 14) 65.93 (9.33) 7.14 (2.85) 3.71 (2.67) 1.75 (0.73)
Epilepsy surgery
No (n = 28) 69.37 (12.29) ns 7.39 (3.10) ns 4.04 (3.80) ns 1.78 (0.87) ns
Yes (n = 8) 69.16 (14.18) 5.13 (4.82) 3.63 (3.46) 1.59 (0.67)
Shunt
No (n = 33) 69.33 (12.70) ns 7.03 (3.71) ns 3.97 (3.85) ns 1.74 (0.86) ns
Yes (n = 3) 69.25 (12.78) 5.33 (1.53) 3.67 (0.58) 1.78 (0.19)
II. Correlations QOLIE-31: total score (r) HADS: anxiety (r) HADS: depression (r) NEO-FFI: neuroticism (r)
Age .07 .35* .14 .17
Number of different seizure types .18 .24 .01 .26
Duration of epilepsy .17 .05 .06 .12
Number of AEDs .07 .03 .01 .08
NEO-FFI: neuroticism .75****
HADS: anxiety .74*** .69***
HADS: depression .62*** .53*** .72***
a Seizures during the past 6 months.
r: Pearson correlation coefﬁcients, M: mean, S.D.: standard deviation; ns: non-signiﬁcant, *p  .05, **p  .01, ***p  .001 (two-tailed).
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A basic requirement for discussion of results was fulﬁlled: the
internal consistency of the self-rating scales was acceptable in our
small sample. Furthermore, we found that comparisons of self-
rating scales’ means did not indicate a special vulnerability to
emotional disorders or reduced HRQOL in the WJE clients with
epilepsy and additional disabilities. The QOLIE-31 total score
turned out to be even higher than in the US-American sample with
epilepsy by Cramer et al.43. In comparison to Germany’s general
population,47 only HADS-anxiety scores were signiﬁcantly ele-
vated in theWJE clientswhereas depression scoreswere not. There
was merely a trend in this direction (p < .10).
HRQOL-results of the general epilepsy population were chosen
for comparison as we did not ﬁnd data of more suitable epilepsy
reference samples for our special subgroup.With amean QOLIE-31
total score of 69 the WJE clients rated their HRQOL as relatively
satisfactory. Very often poorer QOLIE-31 total scores between 40
and 60 were found in epilepsy patient groups.55 Moreover, HADSscores of our special epilepsy sample did not seem to be very
dissimilar to data on the general epilepsy population, at least with
regard to the HADS total score. When differentiating HADS scores
on depression and anxiety other studies in epilepsy showed a
tendency to more depression than in our sample with means
between 4.6 and 5.2 and a tendency to less anxiety with means
between 5.2 and 6.1.49,56
Our data may be surprising, as suggestions of more emotional
problems among clientswith epilepsy and additional disabilities in
contrast to epilepsy only groups appear to be reasonable at ﬁrst
glance. As mentioned, it cannot be completely precluded that
results were positively distorted by data collection with face-to-
face interviews. On the other hand, it seems possible that the
transient residential environment positively affected self-reported
levels of well-being. Living in the WJE could have had a positive
inﬂuence through changing peer groups for social comparisons
and therefore reducing aspiration levels.42 Furthermore, unem-
ployment is a well-known general risk factor for psychiatric
disorders57 and is discussed as a speciﬁc problem for people with
Table 3
Three stepwise regression analyses to predict HRQOL, anxiety and depression
B S.E. b R2 R2adj
Predictors of HRQOLa
Step 1 .56*** .54***
Neuroticism 11.28 1.73 .75**
Step 2 (DR2 = .07*) .63*** .60***
Neuroticism 10.95 1.62 .72***
Epilepsy onset 7.02 2.79 .27*
Predictors of anxietyb
Step 1 .48*** .46***
Neuroticism 3.00 .54 .69***
Step 2 (DR2 = .06*) .54*** .51***
Neuroticism 2.91 .52 .67***
Epilepsy onset 1.88 .90 .25*
Predictors of depressionc
Step 1 .52*** .51***
Neuroticism 3.22 .53 .72***
Step 2 (DR2 = .10**) .62*** .60***
Neuroticism 3.26 .48 .73***
Sex 2.32 .80 .31*
B: Unstandardized regression coefﬁcient; S.E.: standard error; b: standardized
regression coefﬁcient; DR2: change in R2. * p  .05, ** p  .01, *** p  .001.
a Variables incorporated to predict HRQOL: neuroticism, epilepsy onset
(onset < 11 years = 0, onset  11 years = 1).
b Variables incorporated to predict anxiety: neuroticism, epilepsy onset
(onset < 11 years = 0, onset  11 years = 1), age.
c Variables incorporated to predict depression: neuroticism, sex (men = 0,
women = 1).
Table 4
Relations between age at epilepsy onset and other disease variables aswell as socio-
demographic variables
Epilepsy onset p
<11 years (n = 24) 11 years (n = 12) t-tests
M (S.D.) M (S.D.)
Age (years) 24.92 (6.03) 27.08 (5.98) ns
Time spent in WJE (months) 25.89 (19.82) 22.58 (22.57) ns
Number of different seizure
types
3.00 (1.06) 3.08 (1.16) ns
Duration of epilepsy (years) 21.75 (7.61) 10.50 (7.44) ***
Number of AEDs 2.08 (0.78) 2.33 (1.30) ns
Epilepsy onset Fisher’s exact
tests
<11 years
(n) (%)
11 years
(n) (%)
Seizure controla
No seizures 6 (25.0) 2 (16.7) ns
Seizures 18 (75.0) 10 (83.3)
Psychogenic non-epileptic seizures
No 19 (79.2) 8 (66.7) ns
Yes 5 (20.8) 4 (33.3)
Epilepsy-syndrome
Partial 21 (87.5) 11 (91.7) ns
Generalized 3 (12.5) 1 (8.3)
TLE
No 15 (62.5) 9 (75.0) ns
Yes 9 (37.5) 3 (25.0)
Shunt
No 22 (91.7) 11 (91.7) ns
Yes 2 (8.3) 1 (8.3)
Epilepsy surgery
No 17 (70.8) 11 (91.7) ns
Yes 7 (29.2) 1 (8.3)
Vagus nerve stimulation
No 23 (95.8) 11 (91.7) ns
Yes 1 (4.2) 1 (8.3)
Memory impairments
No 17 (70.8) 5 (41.7) ns
Yes 7 (29.2) 7 (58.3)
Sex
Female 13 (54.2) 1 (8.3) **
Male 11 (45.8) 11 (91.7)
Basic education certiﬁcation
No 5 (20.8) 3 (25.0) ns
Yes 19 (79.2) 9 (75.0)
ns: non signiﬁcant, **p  .01, ***p  .001 (two-tailed).
a Seizures during the past 6 months.
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were employed at the time of data collection. Employment
probably had positive inﬂuences on psychiatric symptoms and
probably promoted HRQOL, although the WJE does not provide
work on the general job market but ‘‘supported employment’’ in
sheltered workshops of the Bethel Institute.
4.2. Relationships between the variables and prediction of QOLIE-31
total score and HADS scores
4.2.1. The signiﬁcance of psychological variables
Correlation coefﬁcients between the variables neuroticism,
anxiety, depression and HRQOL turned out to be very high.
Absolute values of r  .70 like in our study were not always found,
but HRQOL has consistently been shown to be more strongly
related to depression, anxiety or neuroticism than to seizure
frequency or neuropsychological variables.21–24,59,60 High correla-
tions may cast doubt on the distinctiveness of HRQOL, depression,
anxiety and neuroticism, butwe also detected differential relations
that argue for further separating these variables: only HRQOL and
anxiety were associated with age at epilepsy onset, but no
signiﬁcant correlation could be found between age at onset and
neuroticism and between age at onset and depression. Moreover,
Johnson et al.23 have already demonstrated that anxiety and
depression independently of one another co-varied with HRQOL.
The theoretical assumptions mentioned in the introduction led
us to choose neuroticism as a psychological predictor of HRQOL,
depression and anxiety in regression analyses. Additionally, the
high inter-correlations of these variables required a solution:
selecting more than one psychological parameter for prediction of
anotherwould have been a violation of the premise of independent
predictors in regression analyses and would have resulted in
intolerable degrees ofmulticollinearity. Regression analyses ﬁnally
strengthened the role of neuroticism with its supposed trait-
character as the variable with strongest inﬂuence on HRQOL,anxiety and depression. These analyses among patients with
epilepsy support the general signiﬁcance of neuroticism for
psychiatric disorders mentioned at the beginning. As causal
inferences cannot be drawn based on such a cross-sectional
design we think that our data form at least a promising base to
study the course of neuroticism, affective disorders and HRQOL in
longitudinal designs. Testa et al.61 recently also found that
personality factors were related to HRQOL and concluded that
the assessment of personality based on the ﬁve-factormodelmight
be useful to identify determinants of HRQOL in patients with
seizures. In their study only long-standing personality dispositions
measuredwith theMinnesotaMultiphasic Personality Inventory-2
(MMPI-2) held as independent predictors of HRQOL in regression
analyses whereas more current mood states measured with the
Proﬁle of Mood States (POMS) did not.
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Among the disease and treatment variables, only epilepsy onset
in adolescence was signiﬁcantly related to less HRQOL and higher
anxiety. Regression analyses underlined its independent role: age
at epilepsy onset was the variable apart from neuroticism that held
as a predictor with an additional variance explanation of 6–7% in
the two criteria HRQOL and anxiety.
Results of the inﬂuence of age at epilepsy onset on HRQOL and
mood are altogether conﬂicting due to very different epilepsy
samples including different age groupswithin the epilepsy samples.
While recent studies among adolescents with epilepsy failed to ﬁnd
a relationship between age at epilepsy onset andHRQOL62 aswell as
psychiatric disturbances,63 studies amongadultswith epilepsy have
already indicated that an epilepsy onset in adolescence and early
adulthood is negatively associated with the QOLIE-89 total score64
and bears the highest suicidal risk.65 Others refer to adolescence in
and of itself as a period of particular psychological vulnerability
without regarding age at onset of epilepsy: adolescence in people
with epilepsywas described as a period of high risk for depression,66
stigma67 and reduced HRQOL.68
The question arises how to explain the inﬂuence of age at
epilepsy onset in adolescence on HRQOL and anxiety. We did not
ﬁnd evidence in our study for conceptualizing epilepsy onset in
adolescence as part of a broader syndrome: no substantial
relationship between this variable and other disease parameters
emerged. Only duration of epilepsy and sex were related to age of
onset: as a matter of course duration was shorter among those
clients with epilepsy onset in adolescence and the group was
nearly exclusively represented by young men. The preponderance
of young men is obviously a sample characteristic. Nevertheless,
the possibility cannot be completely refused that age at disability
onset in adolescence could have been confounded by the inﬂuence
of other disease parameters, e.g. of more severe epilepsy and less
time to adapt to this condition. Some differencesmay have failed to
reach signiﬁcance due to lack of statistical power: for example,
among clients with onset in adolescence were relatively more
individualswith seizures during the past 6months, relativelymore
persons with psychogenic non-epileptic seizures in addition to
epilepsy and relatively more persons with memory deﬁcits
according to caregivers’ observations.
Another possible psychological explanation refers to age at
onset as a true inﬂuential variable. Onset of epilepsy in
adolescence could work as an additional stressor with an impact
on all of the challenges that are characteristic of adolescence.
Adolescence is a period marked by profound developmental
changes in biological, social and psychological domains.66
‘‘Normal’’ challenges were described as identity formation, self-
deﬁnition, or achievement of independence.69 Mastering of these
challenges could be especially difﬁcult when additionally coping
with new onset epilepsy is demanded and could result in poorer
adaptation to epilepsy in later life. Moreover, epilepsy in our
sample was accompanied by cognitive impairment. Especially
adolescentswith cognitive impairment due to new onset epilepsy
are demanded to restructure and readjust their pre-existing
academic self-concepts and self-perceptions completely. Ongoing
conﬂicts between earlier life expectations and later limitations set
by chronic disease could promote worser HRQOL and more
anxiety in later life. In this case, epilepsy onset should be better
described asdisability onset in order to emphasize the importance
of the problematic epilepsy-associated conditions.
As mentioned at the beginning of the article, effects of
some disease parameters such as seizure control or seizure
frequency on HRQOL and psychiatric disorders have often been
discussed. Although we did not ﬁnd signiﬁcant associations, the
distribution of scores shows that means of subgroups oftendiffered as expected (see Table 3): means of subgroups with high
seizure control, without psychogenic non-epileptic seizures or
without memory deﬁcits in everyday situations were higher on
the QOLIE-31 total score and lower on the HADS scores. But these
effects were either weak, and therefore not supported statisti-
cally in our small sample, or did not emerge due to small variance
and very small cell sizes in some subgroups. Furthermore, data
on epilepsy treatment show that individuals in the WJE not
only treated with AEDs, but with vagus nerve stimulation or
epilepsy surgery, did not distort ﬁndings with extreme scores on
questionnaires.
4.2.3. The signiﬁcance of socio-demographic variables
Our results on the relationship of socio-demographic variables
to anxiety and depression may be surprising at ﬁrst glance:
contrary to general research on depression, we found men with
epilepsy to suffer more depression than women. But other authors
have already pointed to the higher vulnerability of men with
epilepsy to depression1,70 or to a gender balance with regard to
depression in epilepsy.71 Up to now it seems unclear why many
studies in epilepsy found men to be at higher risk for depression
than women and what kind of biological or psychosocial factors
must be taken into account to understand this relationship.
We also detected a positive correlation between anxiety and
age. This relationship seems to be a sample characteristic and a
reasonable explanation is difﬁcult to ﬁnd: possibly some older
individuals were already anticipating WJE discharge with unclear
options for the future.
4.3. Limitations
Comparisons with other data are complicated by several
factors: (1) Clients were a speciﬁc subgroup with difﬁcult-to-
treat-epilepsy, not representative of the entire population of
peoplewith epilepsy. Subjects of this studywere only young adults
in short-term residential care without integration in the general
German job market. (2) Due to a very small sample size, possible
effects might have been difﬁcult to secure statistically. (3) Data on
questionnaires were gained by face-to-face interviews with risk of
distortions, e.g. due to social desirability. We were not the ﬁrst to
conduct interviews with the QOLIE-31 and the HADS among
patients with epilepsy. Nevertheless, it has to be mentioned that
the psychometric properties of these questionnaires for the
speciﬁc epilepsy subgroup of this study, including the presentation
mode, have not yet been completely evaluated. Our sample
seemed to be too small so far. (4) Data on disease parameters were
based on residential ﬁles and were not speciﬁcally generated for
this study.
Most importantly, the two major limitations do not admit
generalizations: as a result of the special sample, ﬁndings cannot
be generalized to peoplewith epilepsy in the overall population. As
a result of the small sample size, our regression analytic ﬁndings
seem preliminary: they may be recognized as a tool for further
hypotheses testing.
4.4. Consequences1. This study underlines the importance of the personality trait
neuroticism in correspondence to HRQOL, anxiety and depres-
sion. For a better understanding of the relation of these
variables, they should be further examined in longitudinal
studies.2. Our results suggest that an epilepsy onset in adolescence will
have a negative impact on HRQOL and is associated with
anxiety. They are restricted to people with epilepsy and
M. Endermann, F. Zimmermann / Seizure 18 (2009) 167–175174additional cognitive impairments resulting altogether in a
psychosocial disability. Future research should be based on
larger samples of this epilepsy population with additional
disabilities and should clarify if epilepsy onset is generally of
major importance for current HRQOL and anxiety. If so, such
research should also strive for an improved understanding of
underlying mechanisms.3. With regard to WJE clients, it seems necessary to detect
‘‘epilepsy plus’’ problems more systematically. Moreover, it
seems necessary to discuss speciﬁc intervention strategies for
those clients with high anxiety and depression scores or low
scores on HRQOL.
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